Canine influenza vaccines

Details Canine influenza vaccines Canine influenza vaccines

2005-11-01

2008-09-16

Campbell, Bruce (Department: 1648)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Virus or component thereof

C424S204100, C424S283100, C435S006120, C435S184000

Reexamination Certificate

active

07425336

ABSTRACT:
The present invention encompasses influenza vaccines, in particular canine influenza vaccines. The vaccine may be a recombinant poxvirus vaccine or an inactivated vaccine. The invention also encompasses recombinant poxvirus vectors encoding and expressing influenza antigens, epitopes or immunogens which can be used to protect animals, in particular dogs, against influenza.

REFERENCES:
patent: WO9944633 (1999-09-01), None
Paoletti, Application of pox virus vectors to vacination: An update, Proceedings of the National Academy of Sciences of the United States of America, Oct. 1996, vol. 93, pp. 11349-11353.
Daly et al., Current perspectives on control of equine influenza, Veterinary Research, 2004, vol. 35, pp. 411-423.
Takada et al., Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice, Vaccine, 2003, vol. 21, pp. 3212-3218.
Smirnov et al., Influenza H5 virus escape mutants: immune protection and antibody production in mice, Virus Research, 2004, vol. 99, pp. 205-208.
Youngner et al., Derivation and characterization of a live attenuated equine influenza vaccine virus, American Journal of Veterinary Research, Aug. 2001, vol. 62, No. 8, pp. 1290-1294.
Mayr. Prophylactic Vaccination of Animals and Human Health. Zbl. Bakteriol. Hyg., I Abt. Orig. B, 1985, vol. 180, No. 2-3, pp. 175-189. (German).
Science Daily, Equine influenza Virus Likely Involved in Recent Respiratory Disease Outbreak in Racing Greyhounds. University of Florida news release, Apr. 29, 2004, 2 pages.
Cornell Veterinary Magazine, [Online] 2004, pp. 10-13, Retrieved from the Internet: URL:http://www.vet.cornell.edu
ews/cvmagazine/Fall04/detectives.pdf See p. 11, last sentence of first (incomplete) paragraph.
Crawford P C et al: “Transmission of Equine influenza virus to dogs” Science, American Association for the Advancement of Science US, vol. 310, No. 5747, Oct. 21, 2005, pp. 482-485.
Dubovi EJ, Crawford PC, Donis RO, Castelman WL, Stephenson I. Gibbs EPJ: “Isolation of Equine Influenza Virus from Racing Greyhounds with Fatal Hemorrhagic Pneumonia” Proceedings of the 47th Annual Meeting of American Association of Veterinary Laboratory Diagnosticians, Oct. 2004, p. 158.
Edlund Toulemonde C et al: “Efficacy of a recombinant equine influenza vaccine against challenge with an American lineage H3N8 influenza virus responsible for the 2003 outbreak in the United Kingdom.” The Veterinary Record Mar. 19, 2005, vol. 156, No. 12, Mar. 19, 2005, pp. 367-371.
Enserink Martin: “Epidemiology. Horse flu virus jumps to dogs” Science, American Association for the Advancement of Science US, vol. 309, No. 5744, Sep. 30, 2005, p. 2147.
Karaca Kemal et al: “Evaluation of the ability equine influenza virus of canarypox-vectored vaccines to induce humoral immune responses against canine influenza viruses in dogs” American Journal of Veterinary Research, vol. 68, No. 2, Feb. 2007, pp. 208-212.
Stephensen CB et al: “Canine Distemper Virus (CDV) infection of ferrets as a model for testing Morbillivirus strategies: NYVAC- and ALVAC-based CDV recombinants protect against symptomatic infection” Journal of Virology, The American Society for Microbiology, US, vol. 71, No. 2, Feb. 1997, pp. 1506-1513.
Wood J Met al: “The standardization of inactivated equine influenza vaccines by single-radial immunodiffusion” Journal of Biological Standardization, Academic Press, London, GB, vol. 11, No. 2, Apr. 1983, pp. 133-136.
J.M. Minke et al., “Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination” Veterinary Immunology and Immunopathology, vol. 111, pp. 47-57, 2006.
K. Karaca et al . . , “Recombinant canarypox vectored West Nile virus (WNV) vaccine protects dogs and cats against mosqito MNV challenge” Vaccine 23, pp. 3808-3813, 2005.

Affiliated with

Also associated with

Rating

Canine influenza vaccines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Canine influenza vaccines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Canine influenza vaccines will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3978297